Takeda Pharmaceutical
TAK
$13.23
Share price
-1.12%
Change (1 day)
-21.53%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total debt
Total debt on the balance sheet as of December 2023 : $33.09 B
According to Takeda Pharmaceutical's latest financial reports the company's total debt is $33.09 B. A company’s total debt is the sum of all current and non-current debts.
Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $32.90 B | -7.61% |
| 2022-03-31 | $35.61 B | -15.26% |
| 2021-03-31 | $42.02 B | -10.86% |
| 2020-03-31 | $47.14 B | -9.01% |
| 2019-03-31 | $51.81 B | 458.84% |
| 2018-03-31 | $9.27 B | -9.48% |
| 2017-03-31 | $10.24 B | 49.82% |
| 2016-03-31 | $6.83 B | 12.49% |
| 2015-03-31 | $6.07 B | -27.29% |
| 2014-03-31 | $8.35 B | 34.81% |
| 2013-03-31 | $6.20 B | -5.26% |
| 2012-03-31 | $6.54 B | 2552.65% |
| 2011-03-31 | $0.24 B | 22.71% |
| 2010-03-31 | $0.20 B | 0.69% |
| 2009-03-31 | $0.19 B | 493.27% |
| 2008-03-31 | $33.66 M | -65.88% |
| 2007-03-31 | $98.64 M | -7.69% |
| 2006-03-31 | $0.10 B | -38.11% |
| 2005-03-31 | $0.17 B | 22.94% |
| 2004-03-31 | $0.14 B | 32.03% |
| 2003-03-31 | $0.10 B | -9.28% |
| 2002-03-31 | $0.11 B | -7.75% |
| 2001-03-31 | $0.12 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | -11.36% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | -20.38% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 114.10% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 95.26% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -38.45% | 🇫🇷 France |
 Merck MRK | $35.05 B | 5.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | -30.68% | 🇬🇧 UK |
 Seagen
SGEN | $0.11 B | -99.66% | 🇺🇸 USA |
 Dr. Reddy's RDY | $0.23 B | -99.28% | 🇮🇳 India |